Oxytocin stimulates the synthesis and secretion of PGF2\g=a\ from uterine tissues in vivo and in vitro late in the ovine oestrous cycle. The synthesis of eicosanoids is dependent upon the availability of free arachidonic acid which is released through the activity of arachidonate releasing phospholipases. In the present study, the following hypothesis was tested: the ovine endometrium expresses a cytosolic phospholipase A2 (cPLA2) 
Oxytocin stimulates the synthesis and secretion of PGF2\g=a\ from uterine tissues in vivo and in vitro late in the ovine oestrous cycle. The synthesis of eicosanoids is dependent upon the availability of free arachidonic acid which is released through the activity of arachidonate releasing phospholipases. In the present study, the following hypothesis was tested: the ovine endometrium expresses a cytosolic phospholipase A2 (cPLA2) (Irvine, 1982; Smith, 1989) . Cytosolic phospholipase A2 (cPLA2) is an 85 kDa protein that preferentially hydrolyses arachidonic acid from the sn-2 position of phosphatidylcholine (Clark et ah, 1990; Kramer et ah, 1991) . cPLA2 has been implicated in a number of lipid-mediated signalling processes, including hormonally induced genera¬ tion of prostanoids (Felder et ah, 1990; Lin et ah, 1992a,b) .
Oxytocin-induced secretion of PGF2a from ovine uterine endometrium includes the activation of cPLA2. Aristilochic acid, an inhibitor of PLA2 activity, blocks oxytocin-induced PGF2oL synthesis in vitro, indicating that PLA2 activity is required for this process (Lee and Silvia, 1994) . Cyclic changes in uterine PLA2 activity have been reported in the guinea-pig, in which activity was greater on day 15 versus day 7 of the oestrous cycle (Downing and Poyser, 1983) . Ovarian steroids may control the synthesis of cPLA2 during the oestrous cycle. In rat uterine tissues, oestradiol increases PLA2 activity 12 and 24 h after injection, and this effect is blocked by cyclohexamide (Dey et ah, 1982) . In sheep, uterine secretion of PGF,a also increases during parturition, which is due in part to an increase in uterine responsiveness to oxytocin (Wu et ah, 1996) . Increased PGF2a secretion is associated with an increase in the expression of cPLA2 mRNA and protein (Zhang et ah, 1996) . On the basis of these observations, it is proposed that an increase in endometrial cPLA2 also contributes to the increase in uterine PGF2a secretion that occurs during luteolysis.
The objectives of the present study were (i) to clone the ovine cPLA2 mRNA; (ii) to determine whether expression of Correspondence. (Ausebel, 1994 The effect of day on ovine cPLA2 expression was examined by dot blot hybridization analysis (Ausebel, 1994) 
Statistical analysis
Least squares ANOVA was used to evaluate data with respect to variation due to day, treatment, and the interaction of treatment and day (treatment day) using the General Linear Models procedure (SAS, 1985 (Clark et ah, 1991) . The inferred amino acid sequence shared 94% identity with these two species (Fig. 1) .
When the 834 bp fragment of ovine cPLA2 cDNA was used as a probe, a single 3.4 ± 0.1 kb transcript was identified from endometrial total RNA on all days examined (Fig. 2b) . Overexposure of membranes to film (14 days) did not reveal any additional transcripts. Ethidium bromide staining of the duplicate gel indicated that RNA was intact and differences in signal intensity were not due to loading (Fig. 2a,b) . The signal intensity of cPLA2 mRNA on day 14 appeared to be higher compared with days [11] [12] [13] (Fig. 2b) . Dot blot hybridization analysis was used to quantify differences in ovine cPLA2 mRNA expression during the onset of uterine secretory responsiveness to oxytocin (Table 2) . ANOVA indicated that day of simulated oestrous cycle had no effect on expression of ovine cPLA2. Ovine cPLA2 mRNA was detectable on all days examined, and steady state concentrations remained constant from day 11 to day 14 of the simulated oestrous cycle.
Western blotting analysis
The expression of immunoreactive cPLA2 was examined with a monoclonal IgG raised against an N-terminal peptide of the human cPLA2. Immunoreactive ovine cPLA2 was detected as a 110 kDa band in endometrial tissues from representative ewes on all days examined (Fig. 3) . The mouse macrophage cell line (J774) expresses a cPLA2 (Wijkander and Sundler, 1991) , and lysates from these cells were included as a positive control for the detection of cPLA2. Overexposure of blots (1 h) indicated the presence of additional immunoreactive bands (> 200 kDa and 75 kDa). However, no additional bands were observed in J774 cell lysates, indicating that these bands were not specific for cPLA2. Densitometric 
PGF2asynthesis
Endometrial tissues were collected and examined for the synthesis of PGF2a in response to oxytocin and melittin in vitro to determine whether cPLA2 activity is a limiting factor in the production of PGF2a (Fig. 4) . Arachidonic acid was included as a positive control for the presence of functional prostaglandin synthase. The overall analysis of variance indicated a main effect of treatment (F 3,48; < 0.0001).
However, the main effect of day (F 3,16; = 0.9) (1996) using human specific probes. However, the size of the full-length ovine cPLA2
cDNA has yet to be determined. 
